4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-22-095126
Chief Financial Officer sold 4,669 shares at an average $13.78 ($64,362)
- Chief Financial Officer acquired 1,117 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WENTWORTH KORY JAMES · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-24 | Exercise or conversion : show line 1 in the form | +1,117 | $2.10 | $2,346 | 15,655 | D |
| 2022-08-24 | Sale : show line 2 in the form | −2,817 | $13.52 | $38,093 | 12,838 | D |
| 2022-08-24 | Sale : show line 3 in the form | −301 | $14.23 | $4,282 | 12,537 | D |
| 2022-08-25 | Sale : show line 4 in the form | −1,551 | $14.18 | $21,986 | 10,986 | D |
| Open-market sales · 4,669 sh · avg $13.78 · $64,362 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-24 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −1,117 | 108,807 | D |
Loading xslF345X03/tm2224609-1_4seq1.xml…